Navegar por autor "Martinez Lago, Nieves Purificacion"

A new prognostic score for medical treatment of malignant obstruction

2014- Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Vidal Insua, Yolanda; Barón Duarte, Francisco Javier; [et al.]

Adjuvant chemoradiotherapy with infusional fluorouracil in high-risk adenocarcinoma of the stomach or gastroesophageal junction

2014- Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Vidal Insua, Yolanda; Vázquez Rivera, Francisca; [et al.]

Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction

2015- Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Vidal Insua, Yolanda; Vázquez Rivera, Francisca; [et al.]

Early stage lung cancer treated only with surgery, impact of the 7th AJCC classification

2013- Vieito Villar, María; León Mateos, Luis Ángel; Candamio Folgar, Sonia; López López, Rafael; Vázquez Rivera, Francisca; [et al.]

Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen

2019- Martinez Lago, Nieves Purificacion; Carmona Campos, Marta; Gonzalez Villarroel, P; Salgado Fernández, Mercedes; De La Cámara Gómez, Juan Cruz; [et al.]

Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers

2019- Fernández Montes, Ana; Martinez Lago, Nieves Purificacion; Covela Rúa, Marta; De La Cámara Gómez, Juan Cruz; González Villaroel, Paula; [et al.]

Epidemiology, risk factors, and outcomes in malignant bowel obstruction

2013- Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Barón Duarte, Francisco Javier; Martinez Lago, Nieves Purificacion; [et al.]

FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial

2019- Fernández Montes, Ana; Martinez Lago, Nieves Purificacion; De La Cámara Gómez, Juan Cruz; Covela Rúa, Marta; Cousillas Castiñeiras, A; [et al.]

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population

2020- Martinez Lago, Nieves Purificacion; Vieito Villar, María; Varela Ponte, Rafael; Abdulkader Nallib, Ihab; Carrera Álvarez, Juan José; [et al.]

Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study

2013- Anido Herranz, Urbano; Vieito Villar, María; León Mateos, Luis Ángel; Candamio Folgar, Sonia; López López, Rafael; [et al.]

Low-dose metronomic oral cyclophosphamide plus prednisone for metastatic castration resistant prostate cancer (mCRPC) patients

2013- Anido Herranz, Urbano; Vieito Villar, María; León Mateos, Luis Ángel; Candamio Folgar, Sonia; López López, Rafael; [et al.]

Malignant Pleural Mesothelioma: Observational and Retrospective Analysis of Spanish Database (BEMME). The Spanish Lung Cancer Group (SLCG)

2015- García Campelo, María del Rosario; Martinez Lago, Nieves Purificacion

Metastatic and unresectable biliary tract tumors: A single-center retrospective review

2012- Anido Herranz, Urbano; Vieito Villar, María; Candamio Folgar, Sonia; Gallardo Martín , Maria Elena; López López, Rafael; [et al.]

Neoadjuvant chemotherapy followed by chemoradiation in selected locally advanced squamous cervical cancer

2013- González Patiño, Ezequiel; Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Cueva Bañuelos, Juan Fernando; [et al.]

Neoadyuvant chemotherapy followed by chemorradiation in locally-advanced squamous cervical cancer

2012- González Patiño, Ezequiel; Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Cueva Bañuelos, Juan Fernando; [et al.]

Prognostic factors in stage II colon cancer after radical resection

2014- Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Vidal Insua, Yolanda; Vázquez Rivera, Francisca; [et al.]

Retrospective study of febrile neutropenia

2012- Anido Herranz, Urbano; Vieito Villar, María; León Mateos, Luis Ángel; Candamio Folgar, Sonia; López López, Rafael; [et al.]

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry

2020- Cotes Sanchís, Almudena; Gallego, Javier; Hernandez, Raquel; Arrazubi, Virginia; Custodio, Ana; [et al.]

Use of a new prognostic score as a tool to optimize medical treatment in malignant bowel obstruction

2014- Vieito Villar, María; Candamio Folgar, Sonia; López López, Rafael; Vidal Insua, Yolanda; Vázquez Rivera, Francisca; [et al.]

Zoledronic acid as an antimetastatic agent for different human tumor cell lines

2013- Vieito Villar, María; Alonso Alconada, Lorena; Muinelo Romay , Laura; Abal Posada, Miguel; López López, Rafael; [et al.]

Repositorio digital RUNA

Navegar por autor "Martinez Lago, Nieves Purificacion"

A new prognostic score for medical treatment of malignant obstruction ﻿

Adjuvant chemoradiotherapy with infusional fluorouracil in high-risk adenocarcinoma of the stomach or gastroesophageal junction ﻿

Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction ﻿

Early stage lung cancer treated only with surgery, impact of the 7th AJCC classification ﻿

Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen ﻿

Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers ﻿

Epidemiology, risk factors, and outcomes in malignant bowel obstruction ﻿

FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial ﻿

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population ﻿

Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study ﻿

Low-dose metronomic oral cyclophosphamide plus prednisone for metastatic castration resistant prostate cancer (mCRPC) patients ﻿

Malignant Pleural Mesothelioma: Observational and Retrospective Analysis of Spanish Database (BEMME). The Spanish Lung Cancer Group (SLCG) ﻿

Metastatic and unresectable biliary tract tumors: A single-center retrospective review ﻿

Neoadjuvant chemotherapy followed by chemoradiation in selected locally advanced squamous cervical cancer ﻿

Neoadyuvant chemotherapy followed by chemorradiation in locally-advanced squamous cervical cancer ﻿

Prognostic factors in stage II colon cancer after radical resection ﻿

Retrospective study of febrile neutropenia ﻿

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry ﻿

Use of a new prognostic score as a tool to optimize medical treatment in malignant bowel obstruction ﻿

Zoledronic acid as an antimetastatic agent for different human tumor cell lines ﻿

A new prognostic score for medical treatment of malignant obstruction

Adjuvant chemoradiotherapy with infusional fluorouracil in high-risk adenocarcinoma of the stomach or gastroesophageal junction

Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction

Early stage lung cancer treated only with surgery, impact of the 7th AJCC classification

Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen

Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers

Epidemiology, risk factors, and outcomes in malignant bowel obstruction

FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population

Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study

Low-dose metronomic oral cyclophosphamide plus prednisone for metastatic castration resistant prostate cancer (mCRPC) patients

Malignant Pleural Mesothelioma: Observational and Retrospective Analysis of Spanish Database (BEMME). The Spanish Lung Cancer Group (SLCG)

Metastatic and unresectable biliary tract tumors: A single-center retrospective review

Neoadjuvant chemotherapy followed by chemoradiation in selected locally advanced squamous cervical cancer

Neoadyuvant chemotherapy followed by chemorradiation in locally-advanced squamous cervical cancer

Prognostic factors in stage II colon cancer after radical resection

Retrospective study of febrile neutropenia

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry

Use of a new prognostic score as a tool to optimize medical treatment in malignant bowel obstruction

Zoledronic acid as an antimetastatic agent for different human tumor cell lines